CIRSE 2022: The DEEPER LIMUS Trial: Temporary Spur Stent System for Below-the-Knee Disease

Подробнее о видео

Watch on Radcliffe Vascular:

Dr Marianne Brodmann (Medical University of Graz, AT) joins us in a short interview on the latest data from the DEEPER-LIMUS Trial, originally presented at the CIRSE Conference in 2022.

DEEPER LIMUS aims to evaluate the safety of ReFlow Medical's Temporary Spur Stent System in below-the-knee patients with peripheral arterial disease or critical limb ischemia. The Spur Stent System is designed for the treatment of long, diffuse and severely calcified infrapopliteal disease, and is currently only approved for investigational use.

Recorded Remotely from Graz, 2022.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.